Key Highlights

  • CGNX is trading near $65–$72, up approximately 77% over the past year — the stock has staged one of the most powerful recoveries in the industrial technology sector, driven by a fundamental inflection in machine vision demand that is still in early innings
  • The stock is trading above both the EMA-21 and EMA-50, with both averages rising — the most constructive possible technical configuration, confirming the trend has shifted decisively from bearish to bullish
  • RSI has oscillated between 55 and 70 through the recovery phase — not overbought, not oversold, but trending in the zone of controlled bullish momentum that is sustainable for extended periods in high-quality industrial names
  • Q1 2026 revenue of $268 million beat consensus of $246 million by 8.9% — the largest revenue beat relative to expectations in recent memory and the clearest possible signal that the machine vision recovery cycle has accelerated beyond what models anticipated
  • Goldman Sachs raised its price target to $80, Barclays and Stephens both raised targets to $75 — a coordinated analyst upgrade cycle that typically precedes sustained institutional buying and multiple expansion
  • More than 100 customers globally have expanded their OneVision AI vision platform deployments from single-line trials to multi-site rollouts — a product adoption acceleration that fundamentally changes the revenue duration and predictability of Cognex's business model

Trend Structure: Cyclical Trough Recovery and Acceleration

Phase 1 — Deep Trough and Capitulation (2022 – Mid 2024)

Cognex spent nearly two years in a sustained decline from its $91 all-time high to the $22–$25 cycle low — driven by the collapse of EV manufacturing capex, weakness in consumer electronics assembly, and a broad de-rating of industrial automation multiples. The trough was characterised by valuation compression to levels not seen since the early 2020s, creating a coiled fundamental setup for the eventual recovery.

Phase 2 — Base Formation and Early Recovery (Late 2024 – Mid 2025)

The $22–$25 cycle low proved durable, holding through multiple macro uncertainty events. Institutional buyers began accumulating patiently, with volume on up days beginning to exceed volume on down days — the fundamental signature of professional bottom-fishing in a high-quality cyclical name. Moving averages flattened and RSI rebuilt from extreme oversold levels into the neutral 40–55 range.

Phase 3 — Recovery Acceleration and Breakout (Late 2025 – Jun 2026)

The combination of AI factory automation demand, semiconductor facility buildouts, and the OneVision platform adoption triggered a breakout from the prior base that has delivered a 77% advance in twelve months. The breakout was confirmed by volume expansion, EMA crossovers, and — critically — analyst estimate upgrades driven by fundamental improvement rather than multiple expansion alone.

Fundamental Foundation: AI Vision Is Replacing Human Inspection at Scale

Cognex's machine vision systems are the eyes of the global manufacturing economy — they inspect, measure, and verify every type of discrete component produced at industrial scale, from semiconductors to pharmaceuticals to automobile parts. The company's gross margins above 70% reflect a moat built on 35+ years of proprietary vision algorithms, patent-protected hardware architectures, and switching costs embedded in factory automation workflows.

The Q1 2026 double-digit growth in revenue, EBITDA, and EPS across all major end markets is the most important fundamental datapoint in years — it confirms this is not a single-vertical recovery but a broad-based industrial demand renaissance tied to AI-driven factory modernisation.

The OneVision AI Catalyst

The general availability of OneVision — Cognex's collaborative AI vision development environment — is the most significant product launch in the company's recent history. More than 100 customers globally have expanded from beta testing to multi-site production deployments, with customers reporting faster deployment, improved throughput, and new levels of collaboration between vision engineers and factory operators. Critically, customers are transitioning from single-line point solutions to factory-wide inspection networks — a shift that multiplies the revenue per customer relationship by an order of magnitude and transforms Cognex from a component vendor into a factory intelligence platform.

The new In-Sight 3900 Vision System, built on Qualcomm Dragonwing AI processing, delivers industry-leading speed and accuracy at the edge — addressing the most demanding semiconductor and EV battery inspection applications that prior-generation hardware could not serve reliably.

Key Technical Levels

Resistance: $72–$75 — current trading zone and near-term overhead resistance | $80 — Goldman Sachs price target and major round-number resistance | $91 — all-time high and ultimate bull target

Support: $65–$67 — rising EMA-21 and near-term pullback support | $60–$62 — rising EMA-50 and 38.2% Fibonacci retracement of the recovery | $52–$55 — 50% Fibonacci retracement and prior breakout zone | $29–$32 — 52-week low zone; structural failure scenario

Scenario Analysis

  1. Bullish Continuation: Weekly close above $75 with expanding volume → analyst upgrades continue to $80+ → targets $80–$85 within one quarter as Q2 guidance confirms recovery acceleration
  2. Healthy Consolidation: Price pulls back to EMA-21 at $65–$67 → volume contracts on weakness → RSI resets to 50 → demand re-emerges ahead of Q2 2026 earnings
  3. Bearish Breakdown: Macro industrial slowdown breaks EMA-50 at $60 → downside risk toward $52–$55 Fibonacci support → constructive long-term re-entry zone given Cognex's fundamental quality

Conclusion

Cognex is the clearest expression of the AI factory automation cycle within the mid-cap industrial universe. With Q1 2026 delivering an 8.9% revenue beat across all major end markets, OneVision transitioning from trials to multi-site enterprise deployments, and a coordinated analyst upgrade cycle underway, the stock has all the hallmarks of a breakout that is supported by genuine fundamental improvement rather than multiple expansion alone. Above $75 the next leg targets $80–$85 with the all-time high at $91 in sight. The EMA-21 at $65–$67 is the floor of any constructive pullback.